Daily Stock Opinions and Ratings

Opinions

Jim Cramer - Mad MoneySeattle GeneticsSGENBUYSep 14, 2020

They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.

Jim Cramer - Mad Money

Unknown

$171.79

Stock price when the opinion was issued

$228.74

As of Dec 13, 2023. Market Open.

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Popular Articles

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

© 2000 - 2026 Stockchase Inc.